BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 12108048)

  • 1. [The Raynaud's phenomenon: still current clinical problem].
    Rychlik-Golema W; Adamiec R; Bednarska-Chabowska D; Adamiec J
    Przegl Lek; 2002; 59(1):49-54. PubMed ID: 12108048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Raynaud's phenomenon.
    Herrick AL
    Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raynaud's phenomenon: pathogenesis and management.
    Bakst R; Merola JF; Franks AG; Sanchez M
    J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The determination of the thermal threshold in subjects with Raynaud's disease. A preliminary report of 2 clinical cases].
    Luca S; Romeo S
    Minerva Cardioangiol; 1999 Jun; 47(6):213-7. PubMed ID: 10522147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Raynaud's phenomenon, disease or syndrome?].
    Fiessinger JN
    Rev Prat; 2011 Sep; 61(7):899-903. PubMed ID: 22039719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The natural course of Raynaud's phenomenon].
    Clavijo F; Krahenbuhl B
    Schweiz Med Wochenschr; 1981 Dec; 111(51):2023-7. PubMed ID: 7313657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pathogenic role for endothelin in Raynaud's phenomenon?
    Bottomley W; Goodfield M
    Acta Derm Venereol; 1994 Nov; 74(6):433-4. PubMed ID: 7701873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
    Wigley FM
    Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Raynaud's disease.
    Cooke JP; Marshall JM
    Vasc Med; 2005 Nov; 10(4):293-307. PubMed ID: 16444858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Status of the mechanisms of autonomic regulation in Raynaud's disease].
    Tabeeva GR
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(5):11-3. PubMed ID: 1654687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent achievements in the management of Raynaud's phenomenon.
    Baumhäkel M; Böhm M
    Vasc Health Risk Manag; 2010 Apr; 6():207-14. PubMed ID: 20407628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Raynaud's phenomenon. Practical considerations on the forms secondary to immunomediated systemic diseases].
    Marcolongo R; Corà F; Laveder F; Cavallo M; Busato A; Rigoli AM
    Minerva Med; 1997; 88(7-8):307-10. PubMed ID: 9304074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
    Henness S; Wigley FM
    Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of thrombocytic-vascular and coagulative hemostasis in the pathogenesis of the Raynaud's phenomenon].
    Slutsker GE; Promakhina EK
    Vestn Khir Im I I Grek; 1990 Apr; 144(4):40-3. PubMed ID: 2173227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.